tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

NBIX Stock Latest News

Neurocrine, Sentia Medical Sciences extend CRF research collaboration
The FlyNeurocrine, Sentia Medical Sciences extend CRF research collaboration
3d ago
NBIX
Voyager announces selection of development candidate for GBA1 Program
PremiumThe Fly
Voyager announces selection of development candidate for GBA1 Program
3d ago
NBIX
VYGR
Neurocrine initiates Phase 1 study of NBI-1065890
PremiumThe Fly
Neurocrine initiates Phase 1 study of NBI-1065890
22d ago
NBIX
Neurocrine price target raised to $158 from $148 at JPMorgan
PremiumThe Fly
Neurocrine price target raised to $158 from $148 at JPMorgan
1M ago
NBIX
Spruce Biosciences downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
Spruce Biosciences downgraded to Market Perform from Outperform at Leerink
1M ago
NBIX
SPRB
Neurocrine price target raised to $200 from $170 at Oppenheimer
PremiumThe FlyNeurocrine price target raised to $200 from $170 at Oppenheimer
1M ago
NBIX
Voyager Therapeutics reports selection of gene therapy development candidate
PremiumThe Fly
Voyager Therapeutics reports selection of gene therapy development candidate
2M ago
NBIX
VYGR
JPMorgan biotech analysts to hold an analyst/industry conference call
PremiumThe Fly
JPMorgan biotech analysts to hold an analyst/industry conference call
2M ago
BHVN
ITCI
JPMorgan biotech analysts to hold an analyst/industry conference call
PremiumThe Fly
JPMorgan biotech analysts to hold an analyst/industry conference call
2M ago
BHVN
ITCI
Neurocrine price target raised to $159 from $128 at UBS
PremiumThe Fly
Neurocrine price target raised to $159 from $128 at UBS
2M ago
NBIX
Neurocrine price target raised to $164 from $157 at Guggenheim
PremiumThe Fly
Neurocrine price target raised to $164 from $157 at Guggenheim
2M ago
NBIX
Neurocrine price target raised to $161 from $160 at Deutsche Bank
PremiumThe Fly
Neurocrine price target raised to $161 from $160 at Deutsche Bank
2M ago
NBIX
Neurocrine price target raised to $106 from $100 at Piper Sandler
PremiumThe FlyNeurocrine price target raised to $106 from $100 at Piper Sandler
2M ago
CERE
KRTX
Neurocrine price target raised to $154 from $150 at Canaccord
PremiumThe Fly
Neurocrine price target raised to $154 from $150 at Canaccord
2M ago
CAH
NBIX
Neurocrine price target raised to $140 from $116 at Mizuho
PremiumThe Fly
Neurocrine price target raised to $140 from $116 at Mizuho
2M ago
NBIX
Neurocrine price target raised to $140 from $127 at Wells Fargo
PremiumThe Fly
Neurocrine price target raised to $140 from $127 at Wells Fargo
2M ago
NBIX
Neurocrine price target lowered to $140 from $141 at Citi
PremiumThe Fly
Neurocrine price target lowered to $140 from $141 at Citi
2M ago
NBIX
Neurocrine trading resumes
PremiumThe Fly
Neurocrine trading resumes
2M ago
NBIX
Neurocrine trading halted, volatility trading pause
PremiumThe Fly
Neurocrine trading halted, volatility trading pause
2M ago
NBIX
Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2023 Financial Results and Provides Financial Expectations for 2024
PremiumPress ReleasesNeurocrine Biosciences Reports Fourth Quarter and Fiscal 2023 Financial Results and Provides Financial Expectations for 2024
2M ago
NBIX
Neurocrine sees FY24 INGREZZA net product sales $2.1B-$2.2B
PremiumThe Fly
Neurocrine sees FY24 INGREZZA net product sales $2.1B-$2.2B
2M ago
NBIX
Neurocrine reports Q4 adjusted EPS $1.54, consensus $1.14
PremiumThe Fly
Neurocrine reports Q4 adjusted EPS $1.54, consensus $1.14
2M ago
NBIX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >